"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","source_name_ch2","organism_ch2","characteristics_ch2","molecule_ch2","extract_protocol_ch2","label_ch2","label_protocol_ch2","taxid_ch2","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count"
"GSM237819","prostate_cancer_01","GSM237819","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_01","Homo sapiens","prostate_cancer_01","Gleason_score:3+3","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_01","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_01","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5 labelled) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient.","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237819/GSM237819.gpr.gz","13056"
"GSM237820","prostate_cancer_02","GSM237820","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_02","Homo sapiens","prostate_cancer_02","Gleason_score:3+4","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_02","Homo sapiens","prostate_normal_02","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5 labelled) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient.","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237820/GSM237820.gpr.gz","13056"
"GSM237821","prostate_cancer_04","GSM237821","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_04","Homo sapiens","prostate_cancer_04 Gleason_score:3+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_04","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_04","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237821/GSM237821.gpr.gz","13056"
"GSM237822","prostate_cancer_05","GSM237822","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_05","Homo sapiens","prostate_cancer_05 Gleason_score:3+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_05","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_05","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237822/GSM237822.gpr.gz","13056"
"GSM237824","prostate_cancer_06","GSM237824","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_06","Homo sapiens","prostate_cancer_06 Gleason_score:2+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_06","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_06","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237824/GSM237824.gpr.gz","13056"
"GSM237825","prostate_cancer_07","GSM237825","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_07","Homo sapiens","prostate_cancer_07 Gleason_score:4+5","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_07","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_07","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237825/GSM237825.gpr.gz","13056"
"GSM237826","prostate_cancer_08","GSM237826","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_08","Homo sapiens","prostate_cancer_08 Gleason_score:4+3","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_08","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_08","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237826/GSM237826.gpr.gz","13056"
"GSM237827","prostate_cancer_09","GSM237827","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_09","Homo sapiens","prostate_cancer_09","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_09","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_09","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237827/GSM237827.gpr.gz","13056"
"GSM237828","prostate_cancer_10","GSM237828","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_10","Homo sapiens","prostate_cancer_10 Gleason_score:3+2","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_10","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_10","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237828/GSM237828.gpr.gz","13056"
"GSM237829","prostate_cancer_11","GSM237829","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_11","Homo sapiens","prostate_cancer_11 Gleason_score:4+3","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_11","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_11","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237829/GSM237829.gpr.gz","13056"
"GSM237830","prostate_cancer_12","GSM237830","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_12","Homo sapiens","prostate_cancer_12 Gleason_score:3+3","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_12","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_12","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237830/GSM237830.gpr.gz","13056"
"GSM237831","prostate_cancer_13","GSM237831","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_13","Homo sapiens","prostate_cancer_13 Gleason_score:2+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_13","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_13","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237831/GSM237831.gpr.gz","13056"
"GSM237833","prostate_cancer_14","GSM237833","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_14","Homo sapiens","prostate_cancer_14 Gleason_score:3+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_14","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_14","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237833/GSM237833.gpr.gz","13056"
"GSM237834","prostate_cancer_15","GSM237834","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_15","Homo sapiens","prostate_cancer_15 Gleason_score:3+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_15","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_15","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237834/GSM237834.gpr.gz","13056"
"GSM237836","prostate_cancer_16","GSM237836","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_16","Homo sapiens","prostate_cancer_16 Gleason_score:3+4","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_16","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_16","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237836/GSM237836.gpr.gz","13056"
"GSM237842","prostate_cancer_17","GSM237842","Public on Jan 21 2009","Oct 16 2007","Jan 21 2009","RNA","2","prostate_cancer_17","Homo sapiens","prostate_cancer_17 Gleason_score:3+3","","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy5","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy5-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","prostate_normal_17","Homo sapiens","prostate_normal_adjacent_to_prostate_cancer_17","total RNA","Total RNA was isolated using TRI-Reagent (Molecular Research Center, Inc.) followed by DNAse treatment using RNase-Free DNase (QIAGEN). Purity and quality of the samples was analyzed by agarose gel electrophoresis. cDNA was generated using 5 micrograms total RNA using SuperScript™ Choice System for cDNA Synthesis. Double-stranded cDNA was purified by phenol/chlorophorm followed by ethanol precipitation and subsequently used as template for T7 RNA polymerase amplification using the MEGAscript® T7 kit (Ambion). After DNase treatment, the amplified RNA was purified using RNeasy columns (QIAGEN), quantified spectrophometrically at 260 nm and analyzed by agarose gel electrophoresis.","Cy3","Fluorescent cDNA probe was generated from 2.5 micrograms of amplified RNA in a reaction volume of 25 microlitres containing 50 mM Tris-HCl pH 8.3, 75 mM KCl, 3 mM MgCl2, 0.01 M DTT, 0.5 mM each dATP, dCTP and dGTP and 0.1 mM dTTP, 1.5 micrograms random hexamer primers, 0.6 mM FluoroLink Cy3-dUTP (Amersham) and 10 units of Superscript II reverse transcriptase (Invitrogen) incubated at 37ºC for 120 minutes. After RNA hydrolysis, 10 micrograms of Cot1 Human DNA (GIBCO) were added and the fluorescent probe was concentrated using Microcon YM-30 (Millipore)","9606","Concentrated fluorescent cDNA probes (Cy3 and Cy5) were combined, ethanol precipitated and resuspended in 40 microlitres of SlideHyb Buffer #1 (Ambion). Ten micrograms of polyA (SIGMA) and 4 micrograms of yeast tRNA (GIBCO) were added as blocking agents and the samples were denatured at 95ºC for 2-3 minutes and applied to the prehybridized microarray slide. Prehybridization of microarray slides was performed in 4x SSC, 0.1% SDS and 0.002% BSA for 45 minutes at 65ºC. Hibridization was carried out at 42ºC for 15-20 hours. After hibridization, slides were washed 3 times in 2X SSC, 0.5 % SDS for 15 minutes each at 42ºC and then 3 times in 0.5X SSC, 0.5 % SDS for 15 minutes each at 42ºC.","Slides were scanned for Cy3 and Cy5 fluorescence using Scanarray 5000 XL (GSI Lumonics) and quantified using the GenePix Pro 4.0 software (Axon Instruments Inc.)","Human prostate cancer hybridized against normal adjacent prostate tissue from the same patient","GenePix files were uploaded into the DNMAD module of the Gene Expression Profile Analysis Suite v3.1 (GEPAS; http://www.gepas.org) (Montaner et al. Next station in microarray data analysis: GEPAS. Nucleic Acids Research, 2006, 34 (Web Server issue): W486-W491.) and normalized using print tip loess without background substraction and flagged points were returned as missing values.","GPL1998","Jose M.,,Arencibia","j.arencibia@ufv.es","(34) 917091400","(34) 917091421","Biochemistry and Biotechnology","Universidad Francisco de Vitoria","Ctra M-515 Km 1,800","Pozuelo de Alarcon","Madrid","28223","Spain","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM237nnn/GSM237842/GSM237842.gpr.gz","13056"
